4//SEC Filing
Lynch Karen S 4
Accession 0001127602-22-006296
CIK 0000064803other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:29 PM ET
Size
13.1 KB
Accession
0001127602-22-006296
Insider Transaction Report
Form 4
Rohan Karen
EVP & Pres, Aetna Bus Unit
Transactions
- Award
Common Stock
2022-02-21+257,916→ 327,030 total
Holdings
- 242,408
Stock Option
Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (242,408 underlying) - 211,196
Stock Option
Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (211,196 underlying) - 93,989
Stock Appreciation Rights
Exercise: $37.91From: 2019-02-19Exp: 2026-02-18→ Common Stock (93,989 underlying) - 224,604
Stock Option
Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (224,604 underlying) - 94,369
Common Stock (By Trust)
- 192,741
Stock Appreciation Rights
Exercise: $45.91From: 2019-02-17Exp: 2027-02-16→ Common Stock (192,741 underlying)
Footnotes (7)
- [F1]Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's Aetna Inc. 2010 Incentive Compensation Plan (the "Aetna Plan") on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022.
- [F2]Represents unvested Aetna Inc. Stock Appreciation Rights ("SARs") granted under the Aetna Plan on February 17, 2017 that were converted into CVS Health SARs pursuant to the terms of the CVS/Aetna Merger Agreement. These SARs vest in two substantially equal annual installments beginning on February 17, 2019.
- [F3]Represents unvested SARs granted under the Aetna Plan on February 19, 2016 that were converted into CVS Health SARs pursuant to the terms of the CVS/Aetna Merger Agreement. These SARs vested on February 19, 2019.
- [F4]Option became exercisable in four equal annual installments, commencing 4/1/2020.
- [F5]The number of shares subject to the option were calculated using a 30-day average price.
- [F6]Options became exercisable in four equal installments, commencing 4/1/2021.
- [F7]Option becomes exercisable in four equal installments, commencing 4/1/2022.
Documents
Issuer
CVS HEALTH Corp
CIK 0000064803
Entity typeother
Related Parties
1- filerCIK 0001333760
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 4:29 PM ET
- Size
- 13.1 KB